Literature DB >> 23561600

Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy.

Wen Hua1, Sijia Cao, Jing Cui, David Maberley, Joanne Matsubara.   

Abstract

OBJECTIVE: To identify the underlying reasons for noncompliance among Chinese patients undergoing laser photocoagulation treatment for diabetic retinopathy (DR).
DESIGN: Prospective cohort study. PARTICIPANTS: A total of 262 patients with DR with indications for panretinal photocoagulation and focal laser treatment were recruited.
METHODS: Those who did not complete the prescribed laser treatment were categorized into 2 types of defaulters: Type 1 defaulters were those who did not initiate laser treatment as scheduled; type 2 defaulters were those who did not complete the entire laser sessions, including terminating midterm or defaulting prompt supplement of laser treatment. A standardized questionnaire was given to the 2 types of defaulters to collect information about the reasons for noncompliance. Data were analyzed and subjected to χ(2) test or Fisher exact statistical tests.
RESULTS: The noncompliance rate was 45.5%, which is significantly greater than some developed countries. Unawareness of the necessity for treatment and unawareness of the importance to complete treatment were 2 main reasons leading to noncompliance, representing 28.8% and 36.0%, respectively. Unawareness of the necessity for treatment and fear of laser treatment were more important for type 1 defaulters (29 vs 6 and 11 vs 0, respectively), whereas unawareness of completeness of laser treatment was overweighed in type 2 defaulters (27 vs 13 patients; all P<0.01). These results were likely related to the lack of knowledge about the potential consequences of DR, the underlying principle of laser treatment, and panretinal photocoagulation procedures.
CONCLUSIONS: Developing appropriate education programs targeting specific reasons will help to improve the compliance in patients with DR.
Copyright © 2013 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23561600      PMCID: PMC3947385          DOI: 10.1016/j.jcjo.2012.09.012

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  40 in total

1.  Retinopathy in diabetes.

Authors:  Donald S Fong; Lloyd Aiello; Thomas W Gardner; George L King; George Blankenship; Jerry D Cavallerano; Fredrick L Ferris; Ronald Klein
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy.

Authors:  A K Vine
Journal:  Ophthalmology       Date:  1985-11       Impact factor: 12.079

3.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  Factors that influence the decision to receive treatment for proliferative diabetic retinopathy.

Authors:  P L Reno; C L Arfken; J M Heins; E B Fisher
Journal:  Diabetes Educ       Date:  1997 Nov-Dec       Impact factor: 2.140

5.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

6.  Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

Review 7.  Effectiveness of interventions to promote screening for diabetic retinopathy.

Authors:  Xuanping Zhang; Susan L Norris; Jinan Saadine; Farah M Chowdhury; Tanya Horsley; Sanjat Kanjilal; Carol M Mangione; Ralf Buhrmann
Journal:  Am J Prev Med       Date:  2007-10       Impact factor: 5.043

8.  Cost-effectiveness of detecting and treating diabetic retinopathy.

Authors:  J C Javitt; L P Aiello
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

9.  Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

Authors:  J C Javitt; L P Aiello; Y Chiang; F L Ferris; J K Canner; S Greenfield
Journal:  Diabetes Care       Date:  1994-08       Impact factor: 19.112

10.  Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases.

Authors:  Paul P Lee; Zachary W Feldman; Jan Ostermann; Derek S Brown; Frank A Sloan
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

View more
  7 in total

Review 1.  Can Commercially Available Handheld Retinal Cameras Effectively Screen Diabetic Retinopathy?

Authors:  Jorge Cuadros; George Bresnick
Journal:  J Diabetes Sci Technol       Date:  2016-12-18

Review 2.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

3.  Characteristics of Chinese m-Health Applications for Diabetes Self-Management.

Authors:  Lisa Nie; Bo Xie; Yan Yang; Yan Min Shan
Journal:  Telemed J E Health       Date:  2016-05-12       Impact factor: 3.536

4.  Magnitude and determinants of diabetic retinopathy among persons with diabetes registered at employee health department of a tertiary Eye Hospital of central Saudi Arabia.

Authors:  Rajiv Khandekar; Arif Al Hassan; Hassan Al Dhibi; Abdullah Al Bahlal; Muneera Al-Futais
Journal:  Oman J Ophthalmol       Date:  2015 Sep-Dec

5.  Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.

Authors:  Panshi Yan; Cheng Qian; Wenzhan Wang; Yi Dong; Guangming Wan; Yue Chen
Journal:  Ther Clin Risk Manag       Date:  2016-04-05       Impact factor: 2.423

6.  Influencing factors on compliance of timely visits among patients with proliferative diabetic retinopathy in southern China: a qualitative study.

Authors:  Fang Duan; Yuhong Liu; Xiang Chen; Nathan Congdon; Jian Zhang; Qianyun Chen; Lingling Chen; Xi Chen; Xiulan Zhang; Chengpu Yu; Yizhi Liu
Journal:  BMJ Open       Date:  2017-03-27       Impact factor: 2.692

7.  Exploring Factors Associated with Diabetic Retinopathy Treatment Compliance Behaviour in Cape Town, South Africa.

Authors:  Annalie Wentzel; Zandile June-Rose Mchiza
Journal:  Int J Environ Res Public Health       Date:  2021-11-20       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.